KARA BURNS: Open Payments
NPI 1093962250 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 28 payments from 9 companies in 2025. Trend: 2023 $278 · 2024 $570 · 2025 $1,410
Food & beverage: $764Travel & lodging: $646
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 8 | $1,016 |
| AstraZeneca Pharmaceuticals LP | 7 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $84 |
| Alnylam Pharmaceuticals Inc. | 3 | $72 |
| Novo Nordisk Inc | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $17 |
Products named: Barostim Neo System, LifeVest, ONPATTRO, FARXIGA, ENTRESTO, JARDIANCE, ELIQUIS, Wegovy.
Industry payments across KS — which companies pay providers there.
